MetMAb
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MetMAb, covering 2011-10-18 to 2017-05-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]